The Pharmaceutical Stock Landscape: Assessing Pfizer and Merck’s Outlook Recent fluctuations in the stock market have drawn attention to pharmaceutical giants Pfizer and Merck, raising concerns over patent cliffs and impending challenges. Despite initial apprehensions, subsequent reports offer a more optimistic outlook for both companies, largely due to forthcoming acquisitions.
China’s Efforts to Combat Trademark Fraud: Proposed Guidelines The China Trademark Office (CTMO) recently unveiled a draft guideline titled “Several Provisions on Regulating the Application for Registration of Trademarks” for public review. This initiative aims to establish a screening framework to detect and reject fraudulent trademark applications by malicious entities.
Elon Musk’s Stance: Unleashing Tesla’s Patents and the Impact on Innovation In 2014, Elon Musk initiated an unprecedented move, making Tesla’s patents universally accessible, asserting that “innovation leadership isn’t defined by patents.” Recently reiterating this action, Musk declared the release of most of Tesla’s patents, pledging that the company “won’t
Understanding Trademark Surveys: 10 Critical Pitfalls to Avoid Trademark surveys wield substantial power in litigation, serving to either reinforce or debunk claims of trademark infringement or confusion. However, the effectiveness of these surveys can be severely compromised if certain pitfalls are not navigated adeptly. Here, we outline ten crucial considerations
Understanding the America Invents Act (AIA) In 2011, the passage of the America Invents Act (AIA) by Congress brought about significant changes in patent regulations. While primarily aimed at patent reform, it introduced three key improvements in handling trade secrets. Protecting Secret Information The AIA allowed companies to maintain confidential